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Abstract
The entire substrate translocation pathway in the human GABA transporter (GAT-1) was explored for the endogenous
substrate GABA and the anti-convulsive drug tiagabine. Following a steered molecular dynamics (SMD) approach, in which a
harmonic restraining potential is applied to the ligand, dissociation and re-association of ligands were simulated revealing
events leading to substrate (GABA) translocation and inhibitor (tiagabine) mechanism of action. We succeeded in turning
the transporter from the outward facing occluded to the open-to-out conformation, and also to reorient the transporter to
the open-to-in conformation. The simulations are validated by literature data and provide a substrate pathway fingerprint in
terms of which, how, and in which sequence specific residues are interacted with. They reveal the essential functional roles
of specific residues, e.g. the role of charged residues in the extracellular vestibule including two lysines (K76 (TM1) and K448
(TM10)) and a TM6-triad (D281, E283, and D287) in attracting and relocating substrates towards the secondary/interim
substrate-binding site (S2). Likewise, E101 is highlighted as essential for the relocation of the substrate from the primary
substrate-binding site (S1) towards the cytoplasm.
Citation: Skovstrup S, David L, Taboureau O, Jørgensen FS (2012) A Steered Molecular Dynamics Study of Binding and Translocation Processes in the GABA
Transporter. PLoS ONE 7(6): e39360. doi:10.1371/journal.pone.0039360
Editor: Heinrich Sticht, Universita¨t Erlangen-Nu¨rnberg, Germany
Received April 19, 2012; Accepted May 21, 2012; Published June 21, 2012
Copyright:  2012 Skovstrup et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work was supported by a grant to Søren Skovstrup from the Lundbeck Foundation. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: Laurent David (co-author) is employed in the company H. Lundbeck & Co., but there are no competing interests between the company
and the work descibed in this manuscript. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.
* E-mail: fsj@farma.ku.dk
Introduction
The anti-convulsive agent tiagabine is the only approved drug
that works by inhibiting the gamma-aminobutyric acid (GABA)
transporters (GATs) [1], namely GAT-1. The exact mechanism
and site of inhibition of tiagabine in GAT-1 is, however, still
unclear thereby limiting the development of new selective GAT
inhibitors.
Detailed studies on the interactions between the GATs and their
substrates and inhibitors were until recently hampered by the lack
of a three-dimensional structure. In 2005 the first crystal structure
of a homologues protein, the bacterial leucine transporter (LeuT)
was released [2], revealing 12 transmembrane (TM) helices, two
sodium ions, and a substrate, L-leucine, situated in the centre of
the protein. The structure revealed a so-called outward-facing
occluded state, with the primary substrate binding site (S1) being
occluded, shielded from the extracellular solute by two gating
residues, Y108 and F253, and on top of these a water-mediated
salt bridge formed by R30 and D404. The latter salt bridge was
later recognized as an important interim binding site [3] or even as
a secondary allosteric substrate binding site (S2) [4]. However, the
exact role of this site is still being debated [5]. Subsequently
released crystal structures of LeuT reported outward-facing
occluded conformations in complex with various ligands, and a
single crystal structure revealed an open-to-out conformation with
a small-molecule inhibitor, L-tryptophan, occupying the S1
binding site [6,7,8,9,10]. Based on these crystal structures, diverse
computational simulations were performed to explore the trans-
location of LeuT [4,11,12,13,14].
In recent years, much effort has been focused on developing
non-GAT-1 selective inhibitors to prevent degradation of the
neurotransmitter [15,16,17,18]. Unfortunately, a rational struc-
ture-based approach has not been possible due to the lack of a
three-dimensional structure of a GAT. Recently, we published a
carefully constructed three-dimensional homology model of GAT-
1 using the LeuT crystal structures as templates [19]. With our
GAT-1 homology model and our models of the other three GAT
subtypes constructed following the same protocol, it is now
possible to study ligand interactions in silico, to explore subtype
differences and to ease the quest for subtype selective inhibitors.
Further insight into the binding mechanism, i.e. insight into the
association and translocation mechanism of substrates might give a
clue to important subtype differences located outside the primary
substrate binding site. Likewise, the mechanism of inhibition of
drug transporters from this family is still not fully understood. For
example, tricyclic antidepressants (TCAs) and selective serotonin
reuptake inhibitors (SSRIs), both types being inhibitors of the
serotonin transporter (SERT), were shown to bind in the
extracellular vestibule in the crystal structures of LeuT [6,7,10],
but in mutational studies on SERT their binding site was distinctly
indicated to overlap with the binding site of the substrate, i.e. the
S1 site [20,21]. In the case of the GATs the small substrate-analog
inhibitors generally behave as competitive inhibitors, but with the
larger lipophilic derivatives there is no clear picture about their
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mode of action/inhibition. Thus tiagabine behaves as a compet-
itive and mixed-type inhibitor dependent on the conditions [1],
and other analogs show different inhibition kinetics with the GAT
subtypes, and behave as either competitive, non-competitive,
uncompetitive, or mixed-type inhibitors [22].
Here we present extensive steered molecular dynamics (SMD)
simulations to study the substrate translocation pathway of human
GAT-1. The validity of SMD simulations was first checked for the
streptavidin-biotin complex by Grubmuller et al. [23] and this
method has in recent years been applied to study a wide range of
biological systems and issues (for a review see for example
Sotomayor & Schulten [24] or Genchev et al. [25]) though
primarily related to ligand (un)binding and/or related events, e.g.
allosteric signaling (see for example Amaro et al. [26], Jensen et al.
[27], or Mai et al. [28]). Likewise, the association and
translocation pathway of LeuT was probed by the SMD approach
[4,11]. Here, we extend a published study on the binding mode of
key substrates, GABA and R-nipecotic acid (cf. Figure 1) to GAT-
1. By SMD we simulate dissociation- and association events of the
two substrates in the outward-facing conformation of the
transporter. We complete the translocation pathway by also
steering GABA to the cytoplasmic side, thereby gaining insight
into the full substrate translocation pathway and the underlying
mechanisms involved in substrate translocation with emphasis on
ligand-protein interactions. Finally, we address the riddle of the
association mechanism of tiagabine (cf. Figure 1). Events are
described phenomenologically and are compared and related to
structural knowledge from literature data.
Results
Dissociation of GABA
We previously reported the binding mode of GABA to the
human GABA transporter [19]. In this binding mode, GABA is
located in the S1 site, stabilized by an intramolecular interaction
between the carboxylate and the amine, and by an ionic
interaction with Na1 and hydrogen bonding interactions with
Y60(O), G65(NH), Y140(OH), and S396(OH). This binding mode
was used as input structure for the dissociation simulation of
GABA, and steering was done using displacement restraints, at
0.179, 0.353, and 0.75 A˚/ns in the x-, y-, and z-directions,
respectively, applying a 5 kcal/mol?A˚2 biasing force constant in
each direction. Key details of the simulation are collected in the
left-hand side of Figure 2 in terms of I) traces of the center of mass
(COM) of GABA, II) evolvements of the biasing potential energy,
III) non-bonded interactions between GABA and the protein,
water, sodium and chloride ions, IV-VII) non-bonded interactions
between GABA and residues interacted with along the transloca-
tion pathway (for clarity only residues interacting with an energy
higher than 5 kcal/mol have been included).
Initially the extracellular vestibule was visually scrutinized to
find the least hindered linear pathway from S1 through the
extracellular vestibule to the extracellular side (cf. Figure 1). The
Figure 1. GAT-1 and GAT-1 ligand structures. (a) Three-dimensional representation of the homology model of the human GABA transporter
GAT-1. Structural features mentioned in the text are marked. S1, the substrate binding site; S2, the secondary/interim binding site; TM1 (TM3, TM6
and TM8), transmembrane region 1 (3, 6 and 8); and EL4, extracellular loop 4. (b) Structures of the endogenous ligand gamma-aminobutyric acid,
GABA, R-nipecotic acid, and the anti-convulsive drug tiagabine.
doi:10.1371/journal.pone.0039360.g001
Binding and Translocation in GABA Transporter
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e39360
Figure 2. Dissociation and re-association of GABA. SMD profiles for GABA dissociation using displacement restraints (a), and GABA re-
association using distance restraints (b). For both (a) and (b) the individual figures from top to bottom show the displacement of GABA relative to the
center of mass (COM) of the chemical system (I); the biasing potential energy profile (II); non-bonded interaction energy profiles between GABA and
the protein, water, sodium ions, and chloride ions (III); non-bonded interaction energy profiles between GABA and residues interacted with during
simulation (IV-VII). Figures on the left-hand side share the same time-axis as does figures on the right-hand side. Note, for the displacement restrained
simulation depicted in (A) the displacement vector is specified by its components, hence the biasing potential energy is resolved into its x-, y-, and z-
components, while the biasing potential energy is given for the vector in space in the distance restrained simulation in (B). Generally, changes in the
interaction pattern between GABA and the protein are reflected in e.g. the biasing potential energy profile and vice versa. Most notably is the
departure from the primary binding site, S1. During the initial 6 ns of the dissociation simulation (left-hand side) GABA is firmly keeping the initial
binding mode (i.e. interactions with particularly Y60, G65, Y140, S396 and Na1), while the biasing potential energy (II) is accumulating. After circa 6 ns
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large loop, EL4, situated in the extracellular vestibule is thought to
function as a lid controlling which (and when) ligands enter the
protein. It has been shown to be involved in ligand discrimination
and the conformational mobility of the transporter
[7,29,30,31,32,33]. Following a route leading directly from S1,
through S2, to the extracellular side, the small substrate molecules
seem able to move through the extracellular vestibule without
colliding with EL4. Thus, routes following this path were initially
tested (data not included) and from these a nearly unhindered
route was clearly visualized and employed in the simulation
described below.
Throughout the initial 6.5 ns, GABA is tightly bound to the S1
site in the pose previously described experiencing circa 65 kcal/
mol in non-bonded interaction energies to the protein and
additional 20 kcal/mol to Na1 (Figure 2a, III). After 6.5 ns, and
the accumulation of almost 30 kcal/mol in biasing potential
energy (Figure 2a, II), interactions between GABA and S1 site
residues (Y60, S396 etc.) are one-by-one ruptured and the ligand
starts leaving the binding site (Figure 2a, IV-VII). First, the ligand
amine interactions to Y60(O) and S396(OH) are replaced by
interactions to Y140(OH) and F294(O), and GABA becomes
sandwiched between the aromatic rings of Y140 and F294. The
aliphatic GABA chain is forming hydrophobic contacts to the R69
side chain (at S2). The interaction between the ligand carboxylate
and Y140(OH) is replaced with a contact to Q291(NH2), and the
contact to Na1 is consequently solvated by a water molecule. After
7 ns GABA leaves the S1 site and is almost completely solvated by
a shell of water molecules, though still tightly bound in a network
of water mediated intramolecular and electrostatic interactions
with residues from the S1 site (including Na1) and the S2 site. After
8 ns GABA is increasingly coordinated by S2 site residues, thus a
water molecule is coordinated between Y139(OH), D451(CO2
2)
and the ligand amine, and after 10.2 ns D451 forms direct and
persistent ionic contacts to the ligand amine. The side chain of
R69 is first lining with the aliphatic GABA chain, thereby
obstructing the drift of the ligand leading to a small build-up of the
biasing potential energy (Figure 2a, II), and after 11.5 ns R69
rearranges to form ionic interactions with the GABA carboxylate
via the guanidinium. While following the target movements,
GABA remains directly bound to the S2 site residues for around
6 ns, where after the ligand carboxylate is transferred to Y72,
located one helical turn above R69 in TM1, and then K76,
located one turn above Y72. The interaction between the ligand
amine and D451 is gradually solvated after 17.4 ns, and after
almost 20 ns the GABA carboxylate is fully solvated. Though still
situated in the extracellular vestibule, in an opening between
TM1, TM6, TM10, TM11, and EL2 and EL4a, GABA is highly
solvated by at least one shell of water molecules while it is
following the target movements out of the vestibule. A video
showing the SMD trajectory for the dissociation (and re-
association, see below) of GABA is included as Video S1.
The dissociation simulation was repeated using a distance
restraining protocol, defining the center of the intracellular gate as
the counterweight to which the distance to GABA in the S1 site is
increased during the simulation. In this way GABA is pushed
(rather than being pulled as in the previous setting) from the S1 site
towards the extracellular solute in the least biased setup possible by
this kind of SMD approach. The simulation is summarized in
Figure S1 and S2, which correspond to Figure 2a, I-III and
Figure 2a, III-VII, respectively. In Figure S3 the potential (blue
curve) and kinetic energy (red curve) of the system is followed
throughout the simulation, and the applied force (blue curve) and
the work (green curve) is followed as a function of the distance
travelled by the ligand in the left-hand side of Figure S4.
Generally, the pathway and interaction patterns of this
simulation are very similar to the ones observed from the
displacement restrained simulation outlined above. In this second
simulation less potential energy is accumulated to escape from the
S1 binding site, and the biasing energy profile (Figure S1, II)
generally shows fewer accumulations in accordance with the re-
association described below (and sketched in Figure 2b, II). The
ligand is following a very similar pathway from the S1 site through
the S2 site. Through the extracellular vestibule to the extracellular
solute a more comprehensive interaction pattern is sketched
(compare Figure S1 and S2 from time = 21ns to Figure 2a from
time = 18 ns). Thus, from the S2 site toward the extracellular
solute GABA is following interaction sites at TM1 and TM6 (i.e.
Y72, K76, D287, E283, D281). This interaction pattern is very
much in agreement with the observations from the re-association
simulation described below and supports the proposed pathway in
the extracellular halve of the transporter.
During dissociation of the ligand no significant domain
movements are observed (except for various loops which quite
expectedly continuously changes conformation). The kinetic
energy of the system (Figure S3, red curve) is stable throughout
the simulation, while the potential energy is slightly decreasing
between time 6 ns and 20 ns (Figure S3, blue curve). During this
time interval GABA is leaving the S1 site and moving through the
S2 site to the extracellular vestibule where it does not experience
any further hindrance from the protein. Besides, the system is not
completely in equilibrium (as it is an SMD simulation) and the
energy of the system is therefore not expected to be completely
stable. Likewise, the applied force and the work done on the
system are displayed in Figure S4. From Figure S4 the work done
on the system is accumulating during the initial approximately
21 A˚, corresponding to the distance between the S1 site and the
tip of the EL4 loop which GABA passes right after it has passed
through the S2 site. S1 site residues are generally keeping or re-
taking the initial (occluded state) conformation after GABA has left
the site, except from the two lid residues, Y140 and F294, which
are actually keeping a more open conformation in accordance
with (but not identical to) the conformation observed in the crystal
structure of the open-to-out conformation of LeuT [8].
Dissociation of R-nipecotic Acid
The substrate dissociation simulation was repeated with R-
nipecotic acid, an equipotent GABA-analogue acting as both a
substrate and inhibitor of GAT-1. The trajectory from this
simulation is visualized in Figure S5 in terms of graphs following I)
ligand COM movements and evolvements of the biasing potential
energy, II) non-bonded interactions between R-nipecotic acid and
the protein, water, sodium- and chloride ions, III) non-bonded
interactions between R-nipecotic acid and specific residues
interacted with along the translocation pathway.
The trajectories of the dissociation of GABA and R-nipecotic
acid show very similar events. Not only do they follow the same
the direct ionic or hydrogen bonding interactions to the protein and sodium ion (Na1) are solvated by water molecules (III) thereby facilitating GABA
to depart from the binding site, which is visualized by a sudden change in the COM movements depicted in (I) and in the drop in the biasing
potential energy in (II). At the S2 site the interactions between GABA and the protein are reinforced due to particularly the interactions to R69 and
D451.
doi:10.1371/journal.pone.0039360.g002
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pathway, but they also show very similar force profiles and
interaction profiles. There is, however, one interesting difference
between the unbinding events of the two substrates; compared to
GABA R-nipecotic acid is much more dependent on water
molecules assisting in breaking the interactions to the protein in
the initial binding mode in the S1 pocket. GABA is extremely
flexible and moves in a worm-like fashion, changing interactions
from one hydrogen bonding site to another nearby site. With R-
nipecotic acid water enters the binding site and inserts in the
interactions between the amine and the protein (i.e. the
interactions with S396(OH) and Y60(O)) leading to a lower
energy barrier for changing binding mode. Consequently, he
piperidine can easily rotate and form new hydrogen bonding
interactions to the opposite side of the binding site. In this way, the
much more rigid ligand structure of R-nipecotic acid is compen-
sated for by the involvement of water molecules in the interactions
with the protein. Both ligands are, however, strictly dependent on
water molecules to break the ionic interaction to Na1.
Association of GABA
To support the extracellular substrate pathway outlined above,
the GABA dissociation simulation was continued in the opposite
direction thereby steering the ligand back towards the substrate
binding pocket. For the (re)-association simulation a distance
restraining protocol was applied, with a biasing velocity of 0.75 A˚/
ns and a biasing force constant on 10 kcal/mol?A˚2. With a
distance restraining protocol ligand steering is less biased and the
ligand therefore responds better to favorable interaction sites, and
accordingly the re-association pathway may not be identical to the
dissociation pathway.
The ligand COM traces from the association simulation
(Figure 2b, I) clearly show greater mobility of the ligand in the
extracellular vestibule (initial 13 ns) compared to the first
dissociation simulation (Figure 2a, I) and in full agreement with
the secondly described (less biased) dissociation simulation (Figure
S1,I). Likewise, lower potential energy barriers are observed
during association than in the initially described dissociation
simulation (cf. Figure 2a, II and 2b, II), and in full agreement with
the secondly described dissociation simulation. Early in the
association simulation GABA forms ionic interactions with
K448(NH3
+) and the flexible EL2 loop closes down on GABA
and interacts via D202(CO2
2). Being situated at the entrance to
the extracellular vestibule GABA moves to the opposite side of the
vestibule forming interactions to the TM6 residues E283 and
D287, and K76 in TM1. In this way, positioned between TM1
and TM6 GABA approaches the S2 site and follows largely the
same route to the S1 site as was found in the dissociation
simulation. After almost 36 ns simulation GABA ends up in the S1
site with both GABA and the surrounding residues adopting
essentially the same binding conformation as in the starting
structure of the dissociation simulation, although water molecules
are not depleted from the binding site and are therefore also
interacting with the ligand. In Figure 3 the binding mode obtained
upon (re)-association of GABA is compared to the previously
proposed binding mode (by docking) from which the dissociation
simulation was started.
It is encouraging that three simulations (two dissociation and
one association) with different setups reveal essentially identical
substrate pathways and interaction patterns in the extracellular
half of the protein. The fact that GABA ends up in a binding mode
essentially identical to the initial binding mode, though including
also few interacting water molecules, while also the protein
conformation is preserved, is supportive of both the extracellular
substrate pathway but also the previously hypothesized binding
mode. Figure 2a, IV-VII and 2b, IV-VII reveal that the non-
bonded interactions between the ligand and the protein are on the
same order of magnitude at the S2 and the S1 sites. In addition
Na1, which is located in the S1 site, is forming ionic interactions to
GABA in the order of 20–40 kcal/mol, and thus functions as an
attractive force driving the ligand from the S2 site to the S1 site. A
video showing the SMD trajectory for the dissociation and re-
association of GABA is included as Video S1.
GABA Translocation
In order to determine the complete pathway for the transloca-
tion of substrates across the membrane, we also simulated the
translocation of GABA to the cytoplasm. Thus, GABA was pulled
from the S1 site to the cytoplasmic side via displacement restraints,
starting from the same binding mode in the occluded outward-
facing protein conformation as the dissociation simulations
described above. A second GABA molecule was placed in the
S2 site in accordance with the allosteric role of this site proposed
by Shi et al. [4], though the role of this site as a secondary
allosteric binding site or an interim binding site has been disputed
[5]. Inclusion of a ligand molecule in the S2 site will provide a
rationale of whether the S2 site most likely appears as an allosteric
binding site or rather as an interim binding site, based on the
stability of binding to this site. Visual inspections indicated that the
cytoplasmic substrate pathway follow the z-axis. The velocities in
the x- and y-direction were therefore set to 0 A˚/ns with a low
biasing force constant on 1 kcal/mol to weakly restrain the ligand
movements to the z-direction only. The protein is expected to
undergo significant conformational changes, and the pulling
velocity in the z-direction was therefore only 0.5 A˚/ns (compared
to 0.75 A˚/ns in the dissociation simulations) with a biasing force
constant on 10 kcal/mol?A˚2. In Figure 4a the SMD profiles for the
GABA translocation process are collected.
In accordance with the dissociation simulation GABA shows
very stable binding to the S1 site during the first 8 ns, where after
it slowly moves towards the gating residue, Y60. The ionic
coupling to GABA causes Na1 to leave its binding site and follow
GABA. Consequently, the unwound part of TM6 is slightly
displaced. TM1 and TM8 move slightly apart and open up a
narrow water channel in the vicinity of Y60 leading to the
solvation of the GABA carboxylate and Na1. After 17.6 ns Y60
changes conformation and decisively breaks the interaction
between GABA and Na1 as the tyrosine inserts between them.
TM6 is slightly displaced through a change in the backbone
dihedrals (phi;psi) of G301 (situated in the unwound part of TM6),
from around (100u; 215u) to (2100u; 150u) creating a rather
hydrophobic channel leading from the S1 site towards the
cytoplasmic side. This channel is formed by the side chains of
residues in TM1, TM2, and TM6. The carboxylate of E101
(located in TM2) contacts the GABA amine and assists GABA in
moving from the S1 site into the newly formed channel. The
channel is closed to the cytoplasmic side by a gate formed by F53,
and in a second layer, polar residues from the N-terminal and IL3
(connecting TM6 and TM7), mainly W47, Q106, Y309, N310
and N314. Reaching F53 the biasing potential energy slightly
accumulates until 32.5 ns when GABA moves amine-first in
between the side chain of F53 and the aromatic system of W47.
From here GABA moves relatively unhindered through the gate to
the cytoplasmic side. Figure 5a shows GABA located at the
cytoplasmic gate and the channel leading from the S1 site to the
cytoplasmic site, and in Figure 5b the initial protein structure is
shown and arrows indicate the location, direction and size of the
major protein perturbations. The trace of the full trajectory
pathway is shown in Figure 4b including key residues involved in
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ligand-protein interactions. A video showing the SMD trajectory
for the translocation of GABA is included as Video S2.
During translocation to the cytoplasm the extracellular halve of
the protein is slightly narrowing, while it is expanding in the
cytoplasmic halve. The main determinant of the conformational
perturbations is the cytoplasmic halve of TM6, which moves
downward (toward the cytoplasm) and away from particularly
TM1. Consequently, a tunnel leading from the S1 site to the
cytoplasmic side is formed, and after the ligand has entered the
tunnel the binding site is actually narrowed. This is illustrated in
Figure S6 in which distances between the helices forming the
primary binding site, i.e. TM1, TM3, TM6, and TM8, are
monitored at the cytoplasmic and extracellular side, as well as at
the S1 and S2 sites. The observed domain movements are directly
related to ligand unbinding events, and are clearly reflected in the
monitored distances. For example 1) at 9 ns Na1 is leaving its
binding site leading to a destabilization/movement of particularly
the unwound part of TM6, which is also transmitted to TM3; 2) at
circa 18 ns a water channel is formed; 3) from 20 ns GABA is
leaving the S1 site, and 4) at 35 ns GABA reaches the cytoplasmic
gate. During and after the observed domain movements the
secondary structure elements of the protein are largely conserved.
A similar SMD simulation, where leucine was pulled to the
cytoplasmic side of the LeuT, was previously reported by Shi et al.
and followed up on by Zhao et al. [4,14] In the SMD simulation
from this work the substrate, leucine, follows a pathway emerging
between the cytoplasmic halves of TM1 and TM6, resulting in a
relative down- and outward movement of particularly the inner
halve of TM1. In the present SMD simulation of GAT-1, GABA is
following the same translocation pathway, but instead of plain
TM1 movements we observe a similar and distinct movement of
particularly the cytoplasmic halve of TM6, downward and away
from TM1. In Figure S7 the described domain movements (of
particularly TM1 and TM6) are shown in a cartoon representa-
tion. For the purpose of comparison the representation in Figure
S7 is mimicking the representation used by Zhao et al. [14].
The translocation simulation was repeated in a distance
restrained setup, in which the center of the very extracellular
entrance to the protein was defined as the counterweight to which
the distance to the ligand in the S1 site is increased during the
simulation. This setup is placing very little bias on the
translocation pathway as the ligand is pushed away from its
current position instead of being pulled toward a given point, and
this is considered the least biasing setup possible by this algorithm.
The trajectory is followed in Figure S8 in graphs following I)
GABA COM movements, II) the biasing potential energy profile,
III) non-bonded interactions between GABA and the protein,
water, sodium and chloride ions, and in Figure S9 in terms of non-
bonded interaction profiles between GABA and protein residues
interacting with during translocation. Furthermore, the potential
(blue curve) and kinetic energy (red curve) of the system is followed
throughout the simulation in Figure S10, and in the right-hand
side of Figure S4 the applied force (blue curve) and the work (green
curve) is followed as a function of the distance travelled by the
ligand.
The simulation is showing largely the same trends as in the
displacement restrained simulation. GABA is, though, following a
translocation route slightly closer to TM3. Consequently, instead
of mainly TM6 movements, this translocation simulation shows
equal TM1 and TM6 movements, and is therefore considered
being in-between the displacement restrained simulation described
above and that reported by Shi et al. in the LeuT [4].
Despite of the reported protein perturbations taking place
during translocation, binding site residues are generally keeping or
returning to the initial conformation after passage of the ligand. In
comparison to the dissociation simulation the height of the
potential energy barriers that the ligand has to pass to follow the
target movements is of similar magnitude (compare the biasing
potential energy profiles in Figure 2a/Figure S1 and Figure 4a/
Figure S8 from the two dissociation simulations and the two
translocation simulations). The same conclusion is drawn from the
magnitude of the applied force in the dissociation and transloca-
tion simulation depicted in Figure S4 (blue curve). However, the
green curves in Figure S4 reveal the work done on the system to
add up being three times higher in the translocation simulation.
This is of course expected as the protein is taking an outward-
facing conformation from the beginning of both simulations and
translocation therefore involves greater perturbations of the
protein. From this the involvement of the structural sodium ions
(and the chloride ion) as the driving forces for the release to the
cytoplasmic site can be rationalized (that is, the energetically uphill
transport of the neurotransmitter is driven be the energetically
Figure 3. GABA binding upon re-association. (a) Comparison of the initial binding mode of GABA (from which the dissociation simulation was
started) and the binding mode obtained upon re-association to the S1 binding site. The initial binding mode is color-coded with grey carbon atoms,
and the binding mode obtained by SMD is color-coded with cyan carbon atoms. Red spheres represent water molecules involved in GABA binding
upon re-association (see text), the blue spheres represent the two structural sodium ions, and the green sphere represents the structural chloride ion.
Nitrogen and oxygen atoms are color-coded blue and red, respectively. (b) 2D ligand interaction diagram sketching the binding mode obtained from
the association simulation (prepared via 2D ligand interaction available through Maestro [55]. Red circles represents water molecules involved in
GABA binding, a dashed line represents a hydrogen bond to a protein side chain while a solid line represents an interaction with a protein backbone
atom. Protein residues are color-coded as: green – hydrophobic, blue – polar, gray – glycine, pink – metal.
doi:10.1371/journal.pone.0039360.g003
Binding and Translocation in GABA Transporter
PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e39360
downhill co-transport of the sodium ions [34,35]). Unfortunately,
it was not possible to simulate this by the employed simulation
setups, and the exact transport mechanism of the sodium (and
chloride) ions remains to be fully elucidated.
The role of the S2 site substrate molecule during translocation
of a substrate molecule from the S1 site was evaluated from the
two translocation simulations outlined above (as well as from other
initial simulations not reported here). The S2-site GABA molecule
seems not important for the translocation mechanism, as it tends
to diffuse away from the S2 site, or at least only keep the
interaction to the arginine, R69. However, to completely rule out
its role as an allosteric modulator more experimental evidence is
needed as well as other simulation setups (e.g. MD simulations
applying metadynamics to sample the energy landscape during
translocation with and without a second substrate molecule
occupying the S2 site).
Inhibitor Binding, Tiagabine Association
Tiagabine, an analogue of R-nipecotic acid with a lipophilic
diaromatic side chain attached to the amine, is a GAT-1 selective
inhibitor, but unlike R-nipecotic acid it is not a substrate of the
transporter. While R-nipecotic acid was hypothesized to bind in
Figure 4. Translocation of GABA. (a) SMD profiles for the translocation of GABA using displacement restraints. The individual figures from top to
bottom show: the distance of GABA relative to the center of mass (COM) of the chemical system (I); the biasing potential energy profile (II); the sum of
the non-bonded interaction energies between GABA and the protein, water, sodium- and chloride ions, respectively (III); the electrostatic
contribution to the non-bonded interaction energy profiles between GABA and the protein, water, sodium- and chloride ions (IV); the van der Waals
contribution to the non-bonded interaction energy profiles between GABA and the protein, water, sodium- and chloride ions (V). Compared to the
dissociation simulation in Figure 2 GABA is following the target movements (I) to a larger extend in the beginning of the simulation (i.e. while leaving
the binding site) though still accumulating significant biasing potential energy (II) until after circa 12 ns water is entering the binding site and
disrupts the interaction to particularly the sodium ion, Na1, (III-V). The displacement of GABA from the binding site to the cytoplasmic gate is
associated with a continuous slight accumulation of biasing potential energy, which is expected because of the associated reorientation of the
protein from the occluded outward-facing to the open-to-in conformation of the protein. It is worth noting that while the non-bonded electrostatic
interactions between GABA and the protein are continuously decreasing until GABA reaches the cytoplasmic gate, and particularly until it is leaving
the binding site, the non-bonded vdW interactions are actually slightly increasing until the departure from the binding site, and overall relatively
stable until GABA reaches the cytoplasmic gate. (b) Traces of the substrate translocation pathways from the extracellular dissociation of GABA using
displacement restraints (yellow), extracellular re-association of GABA using distance restraints (purple), and translocation to the cytoplasm using
displacement restraints (red). GABA is shown in the S1 site in cyan spheres, and important residues interacted with during simulation are shown in
green sticks.
doi:10.1371/journal.pone.0039360.g004
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the bottom of the S1 site interacting with residues in TM1 and
TM8, we hypothesized tiagabine to bind in the S1 site interacting
with TM1 and TM6, with the lipophilic side chain placed in the
rather hydrophobic area between the S1 and the S2 sites [19].
Initially, tiagabine was dissociated from the suggested binding
mode in GAT-1 via SMD (data not included), the purpose being
to lift the EL4 loop (residing in the extracellular vestibule) a few
Angstrom to facilitate a less hindered association of tiagabine.
Apart from the EL4 movement no significant domain movements
were observed during the dissociation simulation. The structure
was prepared for the association simulation by moving tiagabine
by hand to the extracellular domain, above EL4, with no direct
contacts to the protein. Subsequently, the system was relaxed
through a short equilibration simulation.
For the association simulation the nipecotic acid part of
tiagabine was used as the steering selection, and steering was
done via distance restraints. The biasing force profile is shown in
Figure 6a, II together with traces of the x,- y,- and z-coordinates of
the COM of the nipecotic acid part of tiagabine in Figure 6a, I.
Figure 6a, III-V show the detailed non-bonded interactions. From
the information in Figure 6a tiagabine interacts with the protein
early in the simulation, but is moving unhindered following the
steering forces until 34 ns. Indeed, early in the simulation
tiagabine interacts with the protein through hydrophobic interac-
tions as it buries the thiophene rings in EL6 and the extracellular
part of TM12. The nipecotic acid part is fixed by water-mediated
contacts to E202 (EL2) and K448 (TM10), which becomes a direct
ionic interaction maintained for 19 ns. At that time tiagabine
approaches the S2 site and the R69–D451 salt bridge, and at
33.6 ns the ligand carboxylate is inserted in the salt bridge via
ionic contacts to R69, and a water mediated contact to D451. The
biasing force slowly accumulates until the salt bridge is broken and
tiagabine moves towards the S1 site. Doing so, the R69 side chain
keeps the interaction to the tiagabine carboxylate and follows the
movements towards the S1 site. With the R69 side chain
sandwiched between tiagabine and TM1, two water molecules
are trapped in a pocket between tiagabine, TM1, TM6, and the
side chain of Q291. The biasing potential energy accumulates
almost 15 kcal/mol and forces one of the water molecules to
become inserted between the chloride and TM6, in the original
position of the S295 side chain. Consequently, S295 and the TM6
backbone from F293 through the unwound part to L300 are
displaced (up to 4.5 A˚ measured for the F294 C-alpha). This
displacement does not show any violation of the backbone
dihedral angles as examined via Ramachandran plots (data not
shown). The displacement of the TM6 stretch slightly and widens
the entrance to the binding site, and tiagabine moves into the S1
site. After 44 ns simulation R69 moves towards its usual
conformation, and tiagabine is positioned in a binding mode very
similar to the one suggested previously [19], with a hydrogen
bonding contact between the amine and F294(O), an ionic
interaction between the carboxylate and Na1, and a water
mediated hydrogen bond between the carboxylate and
Y140(OH). After 52.3 ns tiagabine moves deeper into the S1 site
and the biasing potential starts accumulating dramatically as the
unwound part of TM1 hinders any further advance of tiagabine. A
video showing the SMD trajectory for the association and binding
of tiagabine is included as Video S3.
Perturbations, like the one observed in the unwound part of
TM6, must be examined with great care. However, in spite of the
displacement of the unwound part of TM6, the simulation and the
obtained binding mode are considered reliable for the following
Figure 5. GAT-1 upon substrate translocation. (a) Cartoon representation of GAT-1 after 33 ns simulation with GABA (yellow spheres) located at
the cytoplasmic gate. The orange surface shows the shape of the revealed channel leading from the S1 site to the cytoplasm. (b) Cartoon showing
the backbone of GAT-1 in the initial occluded state conformation, with GABA (yellow spheres) located in the S1 site. The green and red arrows
indicate the direction and size of the principal backbone movements observed during the translocation simulation (from the simulation applying
displacement restraints) (This Figure was prepared with Pymol [59]. In both figures the four TM helices forming the S1 site are highlighted, i.e. TM1
(blue), TM3 (purple), TM6 (pink), and TM8 (red).
doi:10.1371/journal.pone.0039360.g005
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reasons. The simulation was repeated (results not included) with
tiagabine showing a very similar association. We previously
docked tiagabine via induced fit docking (IFD), obtaining a
binding mode very similar to the one obtained by SMD. The poses
from IFD were subjected to several long equilibrium MD
simulations, revealing no significant domain movements. One of
the MD simulations even showed the same mode of interaction
with the Y140(OH), namely a water bridged hydrogen bonding
interaction between the tiagabine carboxylate and the tyrosine.
This mode of interaction was likewise observed in the crystal
structure of LeuT with the small inhibitor tryptophan [8].
Furthermore, in the serotonin transporter (SERT) antidepressants
were very convincingly pinpointed to share binding site with the
substrates, namely the S1 site [20,21].
Discussion
We have presented SMD simulations covering the entire
substrate translocation pathway in GAT-1, and we have also
rationalized the association of the drug tiagabine inhibiting GAT-
1. The present simulations together with substantial information
from the literature enable us to present a qualified and detailed
substrate translocation mechanism focusing on important ligand-
protein interactions.
Figure 6. Tiagabine association. (a) Graphs following the trajectory of the association of tiagabine (using distance restraints). The individual
figures from top to bottom show: the distance of tiagabine relative to the selected point in the bottom of the S1 binding site towards which
tiagabine was pulled (I); the biasing potential energy profile (II); the sum of the non-bonded interaction energy profiles between tiagabine and the
protein, water, sodium- and chloride ions (III); the electrostatic energy contribution to the non-bonded interaction energies between tiagabine and
the protein, water, sodium- and chloride ions (IV); the van der Waals energy contribution to the non-bonded interaction energies between tiagabine
and the protein, water, sodium- and chloride ions (V). Tiagabine is moving unhindered with the target movements through the extracellular vestibule
until it binds to the S2 site after circa 34 ns. From this point the biasing potential energy is repeatedly accumulating though only by small amounts
until tiagabine reaches the S1 site from where it cannot move any further into the protein. Compared to the biasing potential energy accumulated
during translocation of GABA to the cytoplasm (Figure 4) the potential energy barriers for tiagabine reaching the S1 site are considerable lower than
translocation of a substrate. (b) 2D ligand interaction diagram sketching the binding mode obtained from the association of tiagabine towards the S1
site in GAT-1. Residues are colored according to their properties: charged (pink or purple), polar (blue) and hydrophobic (green). Hydrogen bonds are
shown as lines and water molecules as red open circles.
doi:10.1371/journal.pone.0039360.g006
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The role of the charged/polar residues at the extracellular
entrance is to attract and guide the substrate into the extracellular
vestibule. In the simulations this role was fulfilled by EL2
(particularly D202), EL4 (particularly A358 and S359), and EL6
(particularly Y527). EL4, EL5, and EL6 were shown to be
important for ligand selectivity and affinity, and EL4 was also
shown to change the degree of solvent exposure in response to
conformational changes of the protein [29,30,31,32,36]. Thus, the
extracellular loops are attracting and guiding the substrate/
inhibitor into the extracellular vestibule. In the extracellular
vestibule the ligand carboxylate is forming a strong interaction
with the cationic side chain of either K76 or K448, which are
located oppositely in the very extracellular part of TM1 and
TM10, respectively. K448 was shown to be implicated in
interactions with both substrates and antidepressants [31,36,37],
and a K76Q mutant likewise showed some inhibition of transport
[38]. Being bound to K76 the nearby residues in TM6, E283 and
D287, assist in a tight binding and relocation of the ligand towards
the S2 site. The D287G mutant experienced a reduction in
substrate transport to circa 30% of wild type transporter [39].
D287 was also shown to be solvent exposed in the outward-facing
protein conformation, while E283 was insensitive to the applied
inhibition conditions [38]. The ligand is firmly relocated towards
the S2 site, one helical turn at a time, to Y72 and then to R69. Y72
mutants showed significant decrease in transport activity/GABA
uptake [40,41].
At the S2 site R69 and D451 are anchoring the carboxylate and
amine, respectively. R69 was shown to be essential for activity
[41,42,43], and R69 and D451 were both participating in
interactions with TCAs and SSRIs in GAT-1 and in LeuT
[6,7,36]. (The SSRI and TCA binding site in SERT was, however,
pinpointed to the S1 site, and not the S2 site as suggested by e.g.
the LeuT crystal structures [20,21]).
From S2 the substrate approaches the S1 site via a narrow
rather hydrophobic channel, in which mainly W68 and Y139 are
interacting with the ligand. Generally, W68 and Y139 mutants
severely lowered the transporter functionality [41,44,45,46],
although the Y139W mutant actually increased transport activity
[40]. The non-bonded interactions between the ligand and the
protein are on the same order of magnitude at the S1 and the S2
sites. With Na1 (located at the S1 site) contributing by additional
20–40 kcal/mol in interaction energy when interacting with the
ligand carboxylate, Na1 plays a crucial role as the driving force in
attracting the ligand from S2 to S1. Entering the S1 site the ligand
passes through the gating residues, Y140 and F294, which shields
the S1 site to the extracellular media. Mutants of the two gating
residues retained practically no transport activity [38,40], and the
LeuT crystal structures clearly demonstrate their role in closing the
binding site and interacting with the ligand [2,6,7,8,9,10].
With the substrate situated in the S1 site the transporter changes
conformation to an inward-facing conformation, initially leading
to an opening of a water-channel between TM1 (at Y60) and
TM8. Water hydrates the ligand carboxylate and, with Y60
changing conformation, the contact to Na1 is broken and the
tunnel to the cytoplasmic side opens. Y60 has also experimentally
been demonstrated to be a key residue for selectivity [43,47,48].
E101 forms an ionic contact to the GABA amine and assists in
pulling it from S1 into the cytoplasmic tunnel. At this position only
a glutamate is tolerated, as even the chemically equivalent
aspartate, E101D, maintained only 1% GABA transport, and no
transport activity was detected with other mutants [39]. From the
simulation it can be rationalized why an aspartate is not tolerated
at this position, as the aspartate side chain is simply too short to
reach the translocation pathway and interact with the ligand.
From S1 to the cytoplasmic gate the interactions to the protein are
largely of hydrophobic character or water mediated. The
cytoplasmic gate is formed by N-terminal residues (primarily
W47), TM1 residues (mainly F53), TM2 residues (mainly Q106),
and IL3 residues (mainly Y309, N310, and N314). At the N-
terminal R44 and W47 were shown to be essential, as only lysine
was accepted in place of R44 (maintaining 15% activity), and only
aromatic residues were tolerated replacing W47 [49,50,51]. Y309
(IL3) was likewise shown to be important as the Y309F mutant
showed a reduced activity to approx. 25%, whereas both serine
and tryptophan completely abolished transport activity [40].
These experimental observations are rationalized by our simula-
tions by the observation, that Y309 is forming a T-shaped pi-
stacking interaction with W47 and hydrogen binding interaction
(via the hydroxyl group) to the D402 carboxylate, thus in this way
Y309 is forming a very central piece of the intracellular gate.
Finally, the N-terminal was indicated to form a gating domain
with IL4 [52], which in our model is reproduced through
particularly three ionic interaction-pairs, namely D43–R417,
R44–D410, and D45–R420, which are kept until the protein is
taking up the open-to-in conformation.
Methods
We previously described the applied homology model of the
human GABA transporter subtype 1 (GAT-1) in terms of the
construction of the model, and the subsequent docking and MD
simulations of key ligands, GABA, R-nipecotic acid, and tiagabine
[19].
SMD simulations were set up and carried out using Desmond v.
2.2 [53,54] compiled for Maestro [55] with the OPLS-AA 2005
force field, and the included biasing force plugin (documented in
the Desmond User Guide).
Via System Builder the protein was embedded in a POPC lipid
bilayer in an orthorhombic box of TIP3P waters and 0.15 M Na+
and Cl2 ions with 20 A˚ solvent/membrane buffer. The solvate-
pocket script was used to fill water molecules in vacant sites in the
protein and molecules placed between the protein and the
membrane were manually removed. The system was energy-
minimized and equilibrated via the equilibration protocol
described previously [19] including also a 30 ns equilibrium MD
simulation of the membrane and solvent phase in which the
protein heavy atoms were restrained. Simulations were run at
310 K in the NPT ensemble with the Nose-Hoover thermostat
and Martyna-Tobias-Klein barostat using anisotropic coupling. In
SMD simulations weak restraints on the z-coordinate of selected
C-alpha atoms in TM2, TM4, TM5, TM7, and TM9 prevented
the protein in moving in the membrane in response to the exerted
force, and x-y restraints on two C-alpha atoms (Y226 and S515),
prevented the protein in floating in the box (this is only a
visualization issue).
The biasing potential is applied as a time-dependent moving
harmonic spring. With this approach, an external steering force is
applied to selection B (the ligand), which is restrained with respect
to a second selection, A (in the simulations presented here selection
A is defined as the entire chemical system). The steering force is
distributed and scaled by the mass of the atoms of the selection.
The biasing potential was used in two forms, namely as
displacement and distance restraints. That is, distance restraints
are defined as a vector in space specified by a force constant, k,
and a velocity vector relative to the center of mass (COM) of
selection A, and displacement restraints are essentially a vector in
space defined by its components, force constant k (kx, ky, kz) and
velocity vector v (vx, vy, vz).
Binding and Translocation in GABA Transporter
PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e39360
In dissociation and (re)-association simulations in the extracel-
lular part of the protein steering velocities of 0.75 A˚/ns (for
distance restrained simulations) and 0.75 A˚/ns in the z-direction
(for displacement restrained simulations) were applied with
10 kcal/mol?A˚2 force constants. In the distance restrained
simulations the COM of the ligand was pulled towards Y60(O)
situated in the bottom of the S1 binding site. It is important that
the velocities of the target movement (i.e. the restraining position)
are carefully balanced with the pulling forces. Traces of ligand
COM movements (displayed as COM displacement vs. time)
should show smooth traces with small plateaus, reflecting favorable
interaction sites or obstructions of ligand displacement in the
direction of the exerted force. This is in accordance with the
requirements of e.g. Jarzynski’s equality [56,57]. In the translo-
cation simulations the protein is expected to undergo conforma-
tional changes, and consequently slightly slower velocities of
0.5 A˚/ns were applied with 10 kcal/mol?A˚2 force constants.
Unbinding events of both R-nipecotic acid and GABA were
reevaluated and affirmed, thus dissociation of GABA was repeated
with the same displacement restrained setup (not included here) as
well as with displacement restraints using the intracellular gate as
counterweight (selection A) as described in the text. Both
simulations showed very similar dissociation events. Dissociation
of nipecotic acid was repeated twice showing very similar trends.
Simulations with R-nipecotic acid used to study the relationship
between applied forces and pulling velocities (not included in this
manuscript) confirmed the role of water assisting in releasing the
ligand from the binding site in simulations applying low force
constants, while simulations applying too large force constants
showed an unphysical rupture.
Only one tiagabine isomer is included, although it is recognized
that the configuration at the protonated amine might take two
isoforms (and will continuously change between these in solution).
Likewise, it is recognized that the thiophene rings are restrained to
practically one conformation during simulation, although other
conformations are also possible.
Specific residue atoms/groups are specified in parenthesis after
the residue index, e.g. Y60(O) denotes the backbone oxygen of
tyrosine 60, and S396(OH) denotes the side chain hydroxyl of
S396. All graphs are smoothed over 25 frames/data points. For all
graphs following non-bonded interaction energies between the
ligand and specific residues only residues with interaction energies
below 25 kcal/mol are displayed. Notice, these are interaction
energies and does not take solvent effects, entropy etc. into account
and are therefore not to be mistaken for relative or absolute
binding energies or affinities. Trajectories were visualized and
analyzed with VMD [58].
Supporting Information
Figure S1 GABA dissociation using distance restraints.
Graphs following the trajectory of the dissociation of GABA by
distance restraints. The individual figures from top to bottom
show: traces of the COM of GABA showing the distance of GABA
relative to the cytoplasmic gate (I); the biasing potential energy
profile (II); the non-bonded interaction energy profiles between
GABA and the protein, water, sodium- and chloride ions, divided
into the vdW and the electrostatic contributions as well as the sum
of these (III).
(TIF)
Figure S2 GABA dissociation using distance restraints.
Non-bonded interaction energy profiles between GABA and
residues interacted with during simulation.
(TIF)
Figure S3 Evolvement of the kinetic and potential
energy of the chemical system during dissociation of
GABA. The kinetic energy (blue) is stable throughout the
simulation, while the potential energy (red) is slightly decreasing
between time 6 ns and 20 ns. During this time interval GABA is
leaving the S1 site and is moving through the S2 site to the
extracellular vestibule where it does not experience any further
hindrance from the protein. The system is not in full equilibrium
and hence is not the energies of the system. From the low-biased
dissociation simulation with distance restraints.
(TIF)
Figure S4 Applied force and work. Comparison of the
applied force (blue curve) and the accumulated work done on the
system (green curve) as a function of the distance traveled by
GABA for the low-biased distance restrained dissociation (left-
hand side) and translocation (right-hand side) simulations. The
graphs reveal that the height of the potential energy barriers to
cross are of equal magnitude in the two simulations, but the work
necessary to translocate to the cytoplasm is three times the work to
dissociate to the extracellular media.
(TIF)
Figure S5 SMD profile for the dissociation of R-
nipecotic acid. The individual figures from top to bottom show:
the displacement (shown as lines) of the center of mass (COM) of
R-nipecotic acid relative to the COM of the chemical system and
the associated biasing potential energy profile (shown as stacked
surfaces) (I); non-bonded interaction energy profiles between R-
nipecotic acid and the protein, water, sodium- and chloride ions
(II); non-bonded interaction energy profiles between R-nipecotic
acid and residues interacted with during simulation (III).
(TIF)
Figure S6 Intramolecular helix-helix distances from the
GABA translocation simulation using displacement
restraints. Graphs following the distances between the helices
forming the S1 substrate binding site: TM1, TM3, TM6, and
TM8. At the cytoplasmic gate the helices clearly move, and
particularly the inner half of TM6 moves downwards and away
from TM1. At the extracellular side the distances are relatively
stable.
(TIF)
Figure S7 Structural changes associated with reorien-
tation to the inward-open conformation. The initial
outward-facing occluded protein conformation (grey) is compared
to the resulting inward-open conformation (orange) resulting from
the translocation of GABA to the cytoplasm (using displacement
restraints). GABA (shown as light-blue spheres) is located at the
cytoplasmic gate. The helices forming the S1 binding site, TM1,
TM3, TM6, and TM8, are marked. The illustration is comparable
to the illustration by Zhao et al. of LeuT [14].
(TIF)
Figure S8 GABA translocation to the cytoplasm using
distance restraints. The individual figures from top to bottom
show: traces of the COM of GABA showing the distance of GABA
relative to the extracellular entrance to the protein (I); the biasing
potential energy profile (II); the non-bonded interaction energy
profiles between GABA and the protein, water, sodium- and
chloride ions, divided into the vdW and the electrostatic
contributions as well as the sum of these (III).
(TIF)
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Figure S9 GABA translocation to the cytoplasm using
distance restraints. Non-bonded interaction energy profiles
between GABA and residues interacted with during simulation.
(TIF)
Figure S10 Evolvement of the kinetic and potential
energy of the chemical system during translocation of
GABA. The kinetic energy (blue) is stable throughout the
simulation, while the potential energy (red) is slightly decreasing.
The system is not in full equilibrium and hence is not the energies
of the system. From the low-biased translocation simulation with
distance restraints.
(TIF)
Video S1 SMD trajectory of dissociation (by displace-
ment restraints) and re-association (by distance re-
straints) simulations of GABA from the S1 substrate
binding site in the human GAT-1.
(MPG)
Video S2 SMD trajectory of the translocation (using
displacement restraints) of GABA to the cytoplasm of the
human GAT-1 from the occluded outward-facing protein
conformation.
(MPG)
Video S3 SMD trajectory of the association and binding
of tiagabine to human GAT-1.
(MPG)
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